Targeted Drug/Gene/Photodynamic Therapy via a Stimuli-Responsive Dendritic Polymer-Based Nano-Cocktail for Treatment of EGFR-TKI-Resistant Non-small Cell Lung Cancer

Scientists suggested that a stimuli-responsive dendritic polymer-based nano-cocktail therapy may provide a promising approach for the treatment of epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI) resistant NSCLC.